Avastin no benefit to older lung cancer patients: study
(HealthDay) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer ...
Cancer
Apr 17, 2012 |
not rated yet |
0
|
Despite obstacles, fine needle aspiration might be best diagnostic tool
Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are ...
Cancer
Apr 15, 2012 |
not rated yet |
0
Researchers identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that ...
Cancer
Apr 10, 2012 |
5 / 5 (1) |
0
Big advance against cystic fibrosis
Harvard stem cell researchers at Massachusetts General Hospital (MGH) have taken a critical step in making possible the discovery in the relatively near future of a drug to control cystic fibrosis (CF), a fatal lung disease ...
Medical research
Apr 05, 2012 |
not rated yet |
0
|
Researchers derive purified lung and thyroid progenitors from embryonic stem cells
Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have derived a population of pure lung and thyroid progenitor cells in vitro that successfully mimic the developmental milestones ...
Medical research
Apr 05, 2012 |
5 / 5 (1) |
0
|
KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented ...
Cancer
Apr 04, 2012 |
not rated yet |
0
Stopping the spread of a deadly childhood bone cancer
Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs. In a critical step toward finding a way to stop metastasis, researchers at Georgetown Lombardi Comprehensive Cancer Center say ...
Cancer
Apr 03, 2012 |
not rated yet |
0
|
Scientists uncover liver's role in preventing dissemination of lung infection
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition ...
Medical research
Apr 02, 2012 |
5 / 5 (1) |
0
Continued smoking can spread cancer
(Medical Xpress) -- Cigarette smoke not only can cause cancer, but it's also responsible for the spread of it, according to research by UC Merced biochemistry professor Henry Jay Forman.
Cancer
Mar 28, 2012 |
not rated yet |
0
Scientists reprogram cancer cells with low doses of epigenetic drugs
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) ...
Cancer
Mar 22, 2012 |
5 / 5 (1) |
0
|
Research identifies the beginnings of chronic obstructive pulmonary disease
The third most deadly disease in the U.S., chronic obstructive pulmonary disease (COPD), appears to be partly driven by the action of immune cells circulating in the blood entering into the tissues of the lungs. UC Davis ...
Diseases, Conditions, Syndromes
Mar 21, 2012 |
5 / 5 (1) |
0
|
Double whammy: RNAi enhances lung cancer therapy
Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tyrosine kinase inhibitors ...
Cancer
Mar 20, 2012 |
not rated yet |
0
Disabling cancer cells' defenses against radiation
Researchers at Winship Cancer Institute are developing a technique to remove cancer cells' defenses against radiation.
Cancer
Mar 15, 2012 |
5 / 5 (2) |
0
|
BRG1 mutations confer resistance to hormones in lung cancer
Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the characteristics of tumours ...
Cancer
Mar 15, 2012 |
not rated yet |
0
